Clover Health at Growth Conference, Dangote Refinery's $2.5B Raise | August 13, 2026

Executive Summary

Clover Health Investments, Corp. (CLOV) showcased its growth strategy during Canaccord Genuity's 46th Annual Growth Conference, signaling a robust outlook for the company amidst evolving healthcare challenges. Meanwhile, AFC has stepped up to lead a significant $2.5 billion private placement investment in the Dangote Refinery, underscoring confidence in the energy sector's rebounding potential. Additionally, Equatorial S.A. and Mattr Corp. both reported their Q2 2026 results, indicating mixed performance trends as companies navigate a competitive landscape marked by innovation and market fluctuations.

Markets — 8 articles

The investment landscape is witnessing significant activity, with Dangote Refinery attracting substantial capital through private placements, reflecting a resurgence in the energy market.

• Clover Health Investments, Corp. (CLOV) Presents at Canaccord Genuity's 46th Annual Growth Conference - Slideshow — Seeking Alpha (US)
• AFC leads investment in Dangote Refinery’s $2.5bn private placement — Premium Time (NG)
• Equatorial S.A. 2026 Q2 - Results - Earnings Call Presentation — Seeking Alpha (US)
• Mattr Corp. (MATR:CA) Q2 2026 Earnings Call Transcript — Seeking Alpha (US)
• [AUJOURD'HUI Apple] Favorise le chargement de contenu d'actualité dans Siri AI… Devrait renforcer la compétitivité de l'IA — eDaily (KR)